Paul Franks, MSc, MPhil; Simon Griffin, MSc, DM, MRCGP
In patients with type 2 diabetes mellitus, does exercise training improve glycemic control (reduce glycosylated hemoglobin [HbA1c] levels) and reduce body mass?
Studies in all languages were identified by searching MEDLINE (1966 to 2000), EMBASE/Excerpta Medica (1980 to 2000), SPORT DISCUSS (1949 to 2000), HealthSTAR (1975 to 2000), Dissertation Abstracts (1861 to 2000), and the Cochrane Controlled Trials Register; by checking the reference lists of major textbooks, review articles, and relevant articles from the search; and by contacting experts.
Studies were selected if they were randomized controlled trials (RCTs) or controlled clinical trials (CCTs) of exercise interventions lasting ≥ 8 weeks in patients with type 2 diabetes in whom compliance could be verified by direct supervision or diaries.
2 investigators independently extracted data on sample size, baseline and post-treatment means and standard deviations of the intervention and control groups for HbA1c levels and body mass, exercise-program characteristics (type, frequency, duration, intensity, and energy cost), and study quality (randomization, blinding, withdrawals, and concealment).
14 trials (11 RCTs) were included (504 patients, mean age 55 y, 50% men, mean duration of diabetes 4.6 y). The duration of the intervention ranged from 8 to 52 weeks (mean 18 wk). Study quality was moderate to low (mean score 1.6 out of 5 points). 12 trials that compared exercise with no exercise showed reduced HbA1c levels with the exercise program (P < 0.001) (Table). 2 trials that compared diet plus exercise with no diet and no exercise also showed reduced HbA1c levels with the intervention (P = 0.008) (Table). A sensitivity analysis showed no difference between results from RCTs and CCTs (Table). The results did not differ by type of exercise (aerobic vs resistance training). Exercise alone (12 trials, P = 0.60) or combined with diet (2 trials, P = 0.24) did not reduce body mass (Table). The results did not differ when RCTs, CCTs, aerobic training, or resistance training were analyzed separately. Meta-regression analysis showed that the reduction in HbA1c levels could not be predicted by change in body mass, exercise intensity, or total amount of exercise.
In patients with type 2 diabetes mellitus, exercise training reduces HbA1c levels but does not reduce body mass.
Exercise vs no exercise for type 2 diabetes at mean 18 weeks*
*HbA1c = glycosylated hemoglobin; RCTs = randomized controlled trials.
Franks P, Griffin S. Review: Exercise training reduces HbA1c levels but not body mass in type 2 diabetes mellitus. Ann Intern Med. 2002;136:100. doi: https://doi.org/10.7326/ACPJC-2002-136-3-100
Download citation file:
Published: Ann Intern Med. 2002;136(3):100.
Cardiology, Coronary Risk Factors, Diabetes, Endocrine and Metabolism.
Results provided by:
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use